Pathology

Can AI in drug discovery really design the next breakthrough drug?Can AI in drug discovery really design the next breakthrough drug?
The business impact of artificial intelligence across drug discovery workflows.
byTimothy Nathaniel Yakubu,DauLab BioGenomics & Biomedical Services, Kaduna, Nigeria, and Global Health and Infectious Disease Control Institute, Nasarawa State University Keffi, Nigeria.
Subscribe to WHX Insights newsletter
Stay at the forefront of healthcare trends & innovations











